This result could be supported by siRNA silencing experiments, showing that the sensitivity of cells to TMZ was significantly increased after Nrf2 silencing, suggesting that Nrf2 played an important role in IDH1 R12H overexpressing glioma cells. This evidence concerns the gene NFE2L2 and central nervous system cancer.